Metraipolis › archive › dc_38b287fb2166
Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study — Europe PMC PMID:42122175
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42122175
- DOI
- 10.3390/cancers18091379
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T06:07:51.261Z
- SHA-256 of the archived text
6f5b767b94635b1e42890b584d5b4ddfb13368cd852d5460a57b74f30d5e2f84- Stable URL of this page
https://metraipolis.com/documento/dc_38b287fb2166
How to cite
Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study — Europe PMC PMID:42122175 — Europe PMC (en), https://europepmc.org/article/MED/42122175 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38b287fb2166 (Metraipolis archive dc_38b287fb2166, sha256 6f5b767b94635b1e42890b584d5b4ddfb13368cd852d5460a57b74f30d5e2f84)
BibTeX
@misc{dc38b287fb2166,
title = {Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study — Europe PMC PMID:42122175},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42122175},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38b287fb2166; sha256 6f5b767b94635b1e42890b584d5b4ddfb13368cd852d5460a57b74f30d5e2f84},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122175. Agents can read the archived copy with the MCP tool read_document.